Treatment for thoraco-lumbar osteoporotic vertebral body fractures
Message From the Editor-in-Chief

Treatment for thoraco-lumbar osteoporotic vertebral body fractures

Charles B. Simone II

New York Proton Center, New York, NY, USA

Correspondence to: Charles B. Simone II, MD. New York Proton Center, 225 East 126th Street, New York, NY 10035, USA. Email: csimone@nyproton.com.

Submitted May 01, 2023. Accepted for publication May 18, 2023. Published online May 22, 2023.

doi: 10.21037/apm-23-425


To further distinguish Annals of Palliative Medicine as a premier journal in the fields of palliative medicine and palliative care, and to ensure the publication of impactful content, Annals of Palliative Medicine moved from monthly to bimonthly publications beginning with Volume 12 in 2023. The March 2023 issues of Annals of Palliative Medicine featured 9 Original Articles, 6 Editorials, 3 Review Articles, and 3 Editorial Commentary Articles. This Message From the Editor-in-Chief focuses on one of those Original Articles and one of those Editorials, each pertaining to the management of thoraco-lumbar osteoporotic vertebral body fractures.

Thoraco-lumbar osteoporotic vertebral fractures (TLOVF) affect millions of people worldwide each year, with the incidence rising with the increasing aging of the world’s population (1). These fractures can be associated with significant pain and loss of mobility, and they can greatly impact quality of life, mental health, and even overall survival (2). While a cornerstone of treatment for TLOVF is medical management, including analgesics, braces, bed rest, and rehabilitation, these interventions aim to improve pain but do not improve the biomechanics of the spine. Furthermore, adequate pain response is often not achievable with medical management, and prolonged bed rest can lead to disuse syndrome and even worsen bone demineralization, leading to additional risk of osteoporotic-associated fractures.

Two commonly employed percutaneous surgical interventions for TLOVF include vertebroplasty and balloon kyphoplasty. Vertebroplasty can be effective at improving pain but, like medical management, is often infective in normalizing spinal biomechanics. Balloon kyphoplasty is generally thought to be more effective in normalizing spinal biomechanics by optimizing recovery of vertebral body height and kyphosis, and it is perhaps the preferred modality for vertebral fractures associated with vertebral with heigh loss greater than 30% (3,4). However, cement migration may occur with balloon kyphoplasty, as may adjacent vertebral body fractures, occurring in up to 29% of patients post-procedurally (5,6). Notably, though, the use of percutaneous pedicle screw (PPS) placement in combination with balloon kyphoplasty may alleviate the decrease in kyphosis and vertebral body height in the late setting after surgery (7).

Kojima and colleagues compared balloon kyphoplasty combined with PPS to percutaneous vertebroplasty using hydroxyapatite block combined with PPS for the treatment of TLOVF. They retrospectively compared 14 patients receiving each surgical modality treated at Funabashi Orthopaedic Hospital in Funabashi, Japan who had at least 2 years of follow-up. Although the analysis was a retrospective study of a relatively small cohort of 28 patients, the groups of patients were well balanced, and a single surgeon performed all procedures, allowing for nice hypothesis-generating findings.

The investigators found that patients receiving balloon kyphoplasty had shorter operative times, less blood loss during surgery, and shorter hospitalization times. Both procedures lead to similar pain improvements. Both procedures also achieved complete and durable bone union. Balloon kyphoplasty, however, achieved less progression of wedging angle of the fractured vertebra. Specifically, the wedging angle of fractured vertebra at 1 and 2 years following the procedures was significantly higher than that of immediately post-operative assessment for percutaneous vertebroplasty, whereas there was no difference between early and later timepoints following balloon kyphoplasty.

Salle and colleagues from the Department of Neurosurgery, CHU Limoges, Frances wrote an accompanying comprehensive Editorial on this manuscript, and they detailed current trends, limitations, and suggested approaches for percutaneous treatment of TLOVF. They provide great details on current limitations and impediments of the two procedures studied by Kojima et al., including cement leaks, posterior fixation, posterior wall protrusion, secondary adjacent-level fracture, and Magerl classification. They provide insightful suggested management strategies, including treatment approaches for patients with recent osteoporotic fractures that are immediately symptomatic and for patients in whom osteoporotic fractures are initial asymptomatic and later become symptomatic due to kyphosis. For immediately symptomatic patients, the authors recommend early consideration of percutaneous treatment but generally advise against posterior fixation. For patients becoming symptomatic due to kyphosis, the authors recommend percutaneous approaches in patients without neurological deficits due to the lower complication rate of percutaneous procedures relative to open surgical approaches, and they maintain that both balloon kyphoplasty and vertebroplasty have prominent roles in select patient populations.

It is likely that balloon kyphoplasty will become increasingly favored over vertebroplasty, especially with the recent advent of third-generation augmentation that offer the promise of better preserving the recovered body height of the fractured vertebra. The work by Kojima et al. and others is an important step in critically assessing the pros and cons of these two percutaneous treatment approaches, and future randomized trials comparing these modalities would be of interest to advance our understanding of the best way to manage patients with TLOVF.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Palliative Medicine. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://apm.amegroups.com/article/view/10.21037/apm-23-425/coif). The author serves as the Editor-in-Chief of Annals of Palliative Medicine. The author has no other conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Han S, Wan S, Ning L, et al. Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta-analysis of randomised and non-randomised controlled trials. Int Orthop 2011;35:1349-58. [Crossref] [PubMed]
  2. Frankel BM, Monroe T, Wang C. Percutaneous vertebral augmentation: an elevation in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty. Spine J 2007;7:575-82. [Crossref] [PubMed]
  3. Cortet B, Blotman F, Debiais F, et al. Management of osteoporosis and associated quality of life in post menopausal women. BMC Musculoskelet Disord 2011;12:7. [Crossref] [PubMed]
  4. Rao RD, Singrakhia MD. Painful osteoporotic vertebral fracture. Pathogenesis, evaluation, and roles of vertebroplasty and kyphoplasty in its management. J Bone Joint Surg Am 2003;85:2010-22. [Crossref] [PubMed]
  5. Takahashi S, Hoshino M, Yasuda H, et al. Development of a scoring system for predicting adjacent vertebral fracture after balloon kyphoplasty. Spine J 2019;19:1194-201. [Crossref] [PubMed]
  6. Campbell PG, Harrop JS. Incidence of fracture in adjacent levels in patients treated with balloon kyphoplasty: a review of the literature. Curr Rev Musculoskelet Med 2008;1:61-4. [Crossref] [PubMed]
  7. Gu Y, Zhang F, Jiang X, et al. Minimally invasive pedicle screw fixation combined with percutaneous vertebroplasty in the surgical treatment of thoracolumbar osteoporosis fracture. J Neurosurg Spine 2013;18:634-40. [Crossref] [PubMed]
Cite this article as: Simone CB 2nd. Treatment for thoraco-lumbar osteoporotic vertebral body fractures. Ann Palliat Med 2023;12(3):431-433. doi: 10.21037/apm-23-425

Download Citation